Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
6,15-diketo-13,14-dihydroprostaglandin F1alpha → Pga1
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 6,15-diketo-13,14-dihydroprostaglandin F1alpha | HCID 174013 | — |
| 반응물 | Prostaglandin D2 | HCID 448457 | — |
| 반응물 | Dinoprost | HCID 5280363 | — |
| 반응물 | Pgb1 | HCID 5280388 | — |
| 반응물 | Pgj2 | HCID 5280884 | — |
| 반응물 | 11-Epiprostaglandin F2alpha | HCID 5280886 | — |
| 반응물 | 15-keto-PGF2alpha | HCID 5280887 | — |
| 반응물 | 6-Ketoprostaglandin F1 alpha | HCID 5280888 | — |
| 반응물 | PGF1alpha | HCID 5280939 | — |
| 반응물 | Prostaglandin F1beta | HCID 5283070 | — |
| 반응물 | 8-iso-PGF2beta | HCID 5283216 | — |
| 반응물 | Latanoprost | HCID 5311221 | — |
| 생성물 | Pga1 | HCID 5281912 | — |
반응 단계
Prostaglandins which have been determined to be ineffective or have a low effectiveness in stimulating melanogenesis in melanocytes include: PGB1 ; PGD2 ; PGF1α ; PGF2α ; 15-keto PGF2α ; 6-keto PGF1α ; Latanoprost; 6,15-diketo-13,14-dihydro PGF1α ; 8-iso PGF1β ; 8-iso PGF2β ; 11β-PGF1β ; 11β-PGF2α ; and PGJ2.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US05905091 |
| 출처 데이터셋 | uspto-grants-1999_05 |
| ORD ID | ord-d69eb529d5fd4ec7a337919facc9b591 |
| 출처 메모 | uspto-grants-1999_05 |